Inside a case of chronic NoV disease following rituximab-bendamustine therapy for non-Hodgkins lymphoma, stool samples and serum antibodies that block GII

Inside a case of chronic NoV disease following rituximab-bendamustine therapy for non-Hodgkins lymphoma, stool samples and serum antibodies that block GII.4-2009 interaction with…

Read more